Cargando…

s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation

This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Anamika, Sheyi, Rotimi, de la Torre, Beatriz G., El-Faham, Ayman, Albericio, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914932/
https://www.ncbi.nlm.nih.gov/pubmed/33562072
http://dx.doi.org/10.3390/molecules26040864
_version_ 1783657119427330048
author Sharma, Anamika
Sheyi, Rotimi
de la Torre, Beatriz G.
El-Faham, Ayman
Albericio, Fernando
author_facet Sharma, Anamika
Sheyi, Rotimi
de la Torre, Beatriz G.
El-Faham, Ayman
Albericio, Fernando
author_sort Sharma, Anamika
collection PubMed
description This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR clinical isolates, antileishmanial agent, and use as drug nano delivery system). Most of the compounds addressed in our studies and those performed by other groups contain only N-substitution. Exploiting the concept of orthogonal chemoselectivity, first described by our group, we have successfully incorporated different nucleophiles in different orders into s-triazine core for application in peptides/proteins at a temperature compatible with biological systems.
format Online
Article
Text
id pubmed-7914932
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79149322021-03-01 s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation Sharma, Anamika Sheyi, Rotimi de la Torre, Beatriz G. El-Faham, Ayman Albericio, Fernando Molecules Review This review provides an overview of the broad applicability of s-triazine. Our many years working with this intriguing moiety allow us to discuss its wide activity spectrum (inhibition against MAO-A and -B, anticancer/antiproliferative and antimicrobial activity, antibacterial activity against MDR clinical isolates, antileishmanial agent, and use as drug nano delivery system). Most of the compounds addressed in our studies and those performed by other groups contain only N-substitution. Exploiting the concept of orthogonal chemoselectivity, first described by our group, we have successfully incorporated different nucleophiles in different orders into s-triazine core for application in peptides/proteins at a temperature compatible with biological systems. MDPI 2021-02-06 /pmc/articles/PMC7914932/ /pubmed/33562072 http://dx.doi.org/10.3390/molecules26040864 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sharma, Anamika
Sheyi, Rotimi
de la Torre, Beatriz G.
El-Faham, Ayman
Albericio, Fernando
s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
title s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
title_full s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
title_fullStr s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
title_full_unstemmed s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
title_short s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
title_sort s-triazine: a privileged structure for drug discovery and bioconjugation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914932/
https://www.ncbi.nlm.nih.gov/pubmed/33562072
http://dx.doi.org/10.3390/molecules26040864
work_keys_str_mv AT sharmaanamika striazineaprivilegedstructurefordrugdiscoveryandbioconjugation
AT sheyirotimi striazineaprivilegedstructurefordrugdiscoveryandbioconjugation
AT delatorrebeatrizg striazineaprivilegedstructurefordrugdiscoveryandbioconjugation
AT elfahamayman striazineaprivilegedstructurefordrugdiscoveryandbioconjugation
AT albericiofernando striazineaprivilegedstructurefordrugdiscoveryandbioconjugation